From obscurity to ‘superbug’ – The rise of Clostridium difficile
Thomas V. Riley
+ Author Affiliations
- Author Affiliations
Microbiology & Immunology, The University of Western Australia and Division of Microbiology and Infectious Diseases, PathWest Laboratory Medicine (WA), Queen Elizabeth II Medical Centre, Nedlands 6009, WA, Australia. Email: triley@cyllene.uwa.edu.au
Healthcare Infection 15(3) 59-61 https://doi.org/10.1071/HI10028
Published: 22 September 2010
References
[1] Riley TV. Clostridium difficile: a pathogen of the nineties. Eur J Clin Microbiol Infect Dis 1998; 17 137–41.
| CAS | PubMed |
![](../../media/share/OpenURL_Image.gif)
[2] Hurley BW, Nguyen CC. The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea. Arch Intern Med 2002; 162 2177–84.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
![](../../media/share/OpenURL_Image.gif)
[3] Riley TV. Epidemic Clostridium difficile. Med J Aust 2006; 185 133–4.
| PubMed |
![](../../media/share/OpenURL_Image.gif)
[4] Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353 2442–9.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |
![](../../media/share/OpenURL_Image.gif)
[5] Riley TV, Codde JP, Rouse IL. Increased length of hospital stay due to Clostridium difficile-associated diarrhoea. Lancet 1995; 345 455–6.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |
![](../../media/share/OpenURL_Image.gif)
[6] Dubberke ER, Reske KA, Olsen MA, McDonald LC, Fraser VJ. Short- and long-term attributable costs of Clostridium difficile – associated disease in nonsurgical inpatients. Clin Infect Dis 2008; 46 497–504.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
![](../../media/share/OpenURL_Image.gif)
[7] Kuijper EJ, van Dissel JT. Spectrum of Clostridium difficile infections outside health care facilities. CMAJ 2008; 179 747–8.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
![](../../media/share/OpenURL_Image.gif)
[8] Riley TV, Cooper M, Bell B, Golledge CL. Community-acquired Clostridium difficile-associated diarrhoea. Clin Infect Dis 1995; 20(Suppl 2): S263–5.
| PubMed |
![](../../media/share/OpenURL_Image.gif)
[9] Rupnik M. Is Clostridium difficile-associated infection a potentially zoonotic and foodborne disease. Clin Microbiol Infect 2007; 13 457–9.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |
![](../../media/share/OpenURL_Image.gif)
[10] Levett PN. Clostridium difficile in habitats other than the human gastrointestinal tract. J Infect 1986; 12 253–63.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |
![](../../media/share/OpenURL_Image.gif)
[11] Goorhuis A, Bakker D, Corver J, Debast SB, Harmanus C, Notermans DW, et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 2008; 47 1162–70.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |
![](../../media/share/OpenURL_Image.gif)
[12]
[13] Riley TV, Thean S, Hool G, Golledge CL. First Australian isolation of epidemic Clostridium difficile PCR ribotype 027. Med J Aust 2009; 191 706–8.
![](../../media/share/OpenURL_Image.gif)
[14] Eggertson L. Quebec puts up $20 million for C. difficile fight. CMAJ 2005; 172 622.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
![](../../media/share/OpenURL_Image.gif)
[15]
[16] Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010; 23 529–49.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |
![](../../media/share/OpenURL_Image.gif)